Carrie L. Ernst, MD

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York

  • 5Articles
  • 11KReads1
  • 2002–2026Active
  • 20Collaborators

1 Read counts for articles published before 2020 may include some non-human traffic.

About

Carrie L. Ernst, MD, is affiliated with the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai in New York. Her publications, spanning from 2002 to 2026, focus on psychopharmacology and clinical aspects of anxiety, bipolar disorder, major depressive disorder, and schizophrenia/schizoaffective disorders. Her work addresses topics such as the clinical phenomena following antidepressant cessation, psychotropic medication use after psychiatric emergency discharge, delayed mood stabilizer initiation in bipolar disorder, and the reproductive safety profiles of various psychotropic medications. She has frequently collaborated with Joseph F. Goldberg, A. John Rush, Anita H. Clayton, Dan V. Iosifescu, and David W. Goodman.

Publications

JCP
When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?
ASCP Corner

When Do Physical Symptoms After Antidepressant Cessation Reflect Pharmacodynamic versus Non-pharmacodynamic Clinical Phenomena?

August 6, 2026

Focuses on descriptive symptom phenomenology and strategies to minimize discomfort during antidepressant cessation, with possible explanations for unusual, delayed, or protracted symptoms in patients for whom non-pharmacodynamic features may...
, , , et al
JCP
Original Research

The Prescription of Psychotropic Medications for Patients Discharged From a Psychiatric Emergency Service

May 15, 2006

, , , et al
JCP
Original Research

Features Associated With the Delayed Initiation of Mood Stabilizers at Illness Onset in Bipolar Disorder

November 1, 2002

,
PCC
Article

The Reproductive Safety Profile of Mood Stabilizers, Atypical Antipsychotics, and Broad-Spectrum Psychotropics

April 1, 2002

,
JCP
Article

The Reproductive Safety Profile of Mood Stabilizers, Atypical Antipsychotics, and Broad-Spectrum Psychotropics

April 1, 2002

,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe